tiprankstipranks
Trending News
More News >
SinoMab Bioscience Ltd. (HK:3681)
:3681
Hong Kong Market

SinoMab Bioscience Ltd. (3681) Financial Statements

Compare
0 Followers

SinoMab Bioscience Ltd. Financial Overview

SinoMab Bioscience Ltd.'s market cap is currently HK$2.52B. The company's EPS TTM is HK$-0.186; its P/E ratio is ―; SinoMab Bioscience Ltd. is scheduled to report earnings on March 24, 2025, and the estimated EPS forecast is HK$―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Income Statement
Total Revenue¥ 2.03M¥ 1.36M¥ 4.03M¥ 26.66M¥ 12.76M
Gross Profit¥ 543.00K¥ 422.00K¥ 4.03M¥ 26.66M¥ 12.76M
Operating Income¥ -161.35M¥ -229.57M¥ -258.93M¥ -305.86M¥ -162.65M
EBITDA¥ -142.79M¥ -200.46M¥ -244.29M¥ -296.43M¥ -158.61M
Net Income¥ -185.14M¥ -243.11M¥ -284.16M¥ -288.19M¥ -122.60M
Balance Sheet
Cash & Short-Term Investments¥ 106.88M¥ 234.66M¥ 422.38M¥ 589.53M¥ 916.20M
Total Assets¥ 753.10M¥ 847.79M¥ 1.01B¥ 1.04B¥ 1.13B
Total Debt¥ 482.27M¥ 450.81M¥ 357.18M¥ 275.46M¥ 97.84M
Net Debt¥ 420.37M¥ 247.14M¥ 11.47M¥ -287.52M¥ -712.53M
Total Liabilities¥ 560.19M¥ 552.20M¥ 498.77M¥ 361.43M¥ 142.51M
Stockholders' Equity¥ 192.91M¥ 295.58M¥ 509.57M¥ 680.23M¥ 987.01M
Cash Flow
Free Cash Flow¥ -172.30M¥ -237.74M¥ -413.29M¥ -345.30M¥ -217.29M
Operating Cash Flow¥ -130.80M¥ -133.85M¥ -300.54M¥ -147.06M¥ -141.34M
Investing Cash Flow¥ -94.48M¥ -96.92M¥ -81.36M¥ -137.70M¥ -179.22M
Financing Cash Flow¥ 73.27M¥ 82.27M¥ 102.28M¥ 57.52M¥ -18.81M
Currency in CNY

SinoMab Bioscience Ltd. Earnings and Revenue History

SinoMab Bioscience Ltd. Debt to Assets

SinoMab Bioscience Ltd. Cash Flow

SinoMab Bioscience Ltd. Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis